Certara will announce Q4 and 2024 financial results on February 26, 2025, followed by investor conference participation.
Quiver AI Summary
Certara, Inc. announced that it will release its financial results for the fourth quarter and full year of 2024 on February 26, 2025, after market close, with a conference call scheduled for 5:00 PM ET to discuss these results. Interested investors must register online to participate, with prior registration recommended. Additionally, Certara's management will attend two upcoming investor conferences: the Leerink Partners Global Healthcare Conference on March 11 and the Barclays 27th Annual Global Healthcare Conference on March 12. Live and archived webcasts of the events will be available on Certara's website.
Potential Positives
- Certara is set to release its financial results for the fourth quarter and full year of 2024, indicating transparency and engagement with investors.
- The planned conference call provides an opportunity for direct communication between company management and investors, fostering trust and interest in the company's performance.
- Participation in notable investor conferences (Leerink Partners Global Healthcare Conference and Barclays 27th Annual Global Healthcare Conference) enhances the company's visibility and attractiveness to potential investors.
- Offering live and archived webcasts of events demonstrates a commitment to keeping investors informed and engaged with the company's developments.
Potential Negatives
- e
FAQ
When will Certara release its Q4 and full year 2024 financial results?
Certara will release its financial results on February 26th, 2025, after market close.
What time is the Certara financial results conference call?
The conference call will take place at 5:00 PM ET on February 26th, 2025.
How can I register for the Certara conference call?
Interested investors must register online, preferably at least one day in advance.
Where can I find information about Certara's investor conferences?
Details about the investor conferences can be found in the "Investors" section of the Certara website.
What services does Certara provide to its clients?
Certara offers biosimulation software, technology, and services to accelerate drug discovery and development.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CERT Insider Trading Activity
$CERT insiders have traded $CERT stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CERT stock by insiders over the last 6 months:
- LEIF E PEDERSEN (PRESIDENT, CHIEF COMMERCAL OFF) sold 51,224 shares for an estimated $578,318
- PATRICK F SMITH (PRESIDENT, DRUG DEV SOLUTIONS) sold 5,409 shares for an estimated $59,661
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CERT Hedge Fund Activity
We have seen 111 institutional investors add shares of $CERT stock to their portfolio, and 125 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAILLIE GIFFORD & CO removed 8,357,301 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $97,863,994
- DIMENSIONAL FUND ADVISORS LP added 4,932,885 shares (+160.2%) to their portfolio in Q3 2024, for an estimated $57,764,083
- TEACHER RETIREMENT SYSTEM OF TEXAS added 4,000,603 shares (+inf%) to their portfolio in Q3 2024, for an estimated $46,847,061
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 3,616,651 shares (-69.3%) from their portfolio in Q3 2024, for an estimated $42,350,983
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 3,354,430 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $39,280,375
- BROWN BROTHERS HARRIMAN & CO added 2,330,615 shares (+inf%) to their portfolio in Q3 2024, for an estimated $27,291,501
- WASATCH ADVISORS LP added 1,651,076 shares (+22.4%) to their portfolio in Q3 2024, for an estimated $19,334,099
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26 th , 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.
Investors interested in listening to the conference call are required to register online . It is recommended to register at least one day in advance.
Certara also announced that company management will participate in the following investor conferences:
-
Leerink Partners Global Healthcare Conference
Date and Time: Tuesday, March 11 th at 1:00PM ET
-
Barclays 27
th
Annual Global Healthcare Conference
Date and Time: Wednesday, March 12 th at 11:30AM ET
Live and archived webcasts of these events will be available on the “Investors” section of the Certara website at https://ir.certara.com/ .
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
[email protected]
Media Contact:
Alyssa Horowitz
[email protected]